Citation Impact
Citing Papers
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
2009
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Colorectal cancer statistics, 2020
2020 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
The Third Intergroup Rhabdomyosarcoma Study.
1995 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Pancreatic cancer
2004 Standout
Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
2012
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
2001
Cancer to bone: a fatal attraction
2011 Standout
Current perspectives in muscle invasive bladder cancer
2002
Secondary leukemias induced by topoisomerase-targeted drugs
1998
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low‐dose etoposide on intergroup rhabdomyosarcoma study III: An interim report
1994
The present and future role of photodynamic therapy in cancer treatment
2004 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
2011
Racial Disparities in the Outcomes of Communication on Medical Care Received Near Death
2010
Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
2008
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
2006
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Bladder Preservation Strategies
2014
Distressful symptoms after radical radiotherapy for urinary bladder cancer
2002
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Taxanes in the Treatment of Non-Small Cell Lung Cancer
2006
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Drug-Induced Acute Pancreatitis: An Evidence-Based Review
2007
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Urothelial carcinoma management in elderly or unfit patients
2016
Cancer treatment and survivorship statistics, 2012
2012 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
The role of antisense oligonucleotides in the treatment of bladder cancer
2002
Breakthrough pain in cancer patients: Pathophysiology and treatment
1998
Pancreatic Cancer
2010 Standout
Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
2008 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
2013
Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival
2000
Molecular Pathogenesis of MDS
2005
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Lymphedema beyond breast cancer
2010 Standout
Mortality and cancer incidence following radiotherapy for seminoma of the testis
1994
Challenges in the treatment of bladder cancer
2006
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
2015
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
2004
Hematological changes during androgen deprivation therapy
2012
Pancreatic cancer
2011 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
2009
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
2009
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer
2003
In Chemotherapy for Lung Cancer, Sometimes Less is More
2013
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors.
2003
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
2012
Why Is Spiritual Care Infrequent at the End of Life? Spiritual Care Perceptions Among Patients, Nurses, and Physicians and the Role of Training
2012
Bladder Cancer
2020 Standout
Arterial hypertension and cancer
2013
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials
2005
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Is the Epstein-Barr Virus Involved in Hodgkin's Disease?
1989
Cancer treatment and survivorship statistics, 2016
2016 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer
2001
Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer
2000
Viruses in Human Cancers
1991 StandoutScienceNobel
A Systematic Review of Barriers and Facilitators to Minority Research Participation Among African Americans, Latinos, Asian Americans, and Pacific Islanders
2013 Standout
Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?
2006
Cancer treatment and survivorship statistics, 2019
2019 Standout
African American Participation in Alzheimer’s Disease Research That Includes Brain Donation
2011
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Religiousness and Spiritual Support Among Advanced Cancer Patients and Associations With End-of-Life Treatment Preferences and Quality of Life
2007
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
2007
The Effects of the Palliative Medicine Consultation on the DNR Status of African Americans in a Safety-Net Hospital
2012
Health and Spirituality
2017 Standout
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
2001
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
2001 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
2006
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
2017
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Second-Line Systemic Therapy for Metastatic Urothelial Carcinoma of the Bladder
2013
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of William Tester being referenced
Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
2014
A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer
1999
Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain
1997
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group
2005
Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
2011
Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
1995
Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
1996
Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12
1993
Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy
1996
Long-term outcomes in patients with muscle-invasive bladder cancer after bladder-preserving combined-modality therapy: A pooled analysis of RTOG 8802, 8903, 9506, 9706, 9906, and 0233.
2012
Approaching the End of Life: Attitudes, Preferences, and Behaviors of African-American and White Patients and Their Family Caregivers
2003
Vinorelbine-induced pancreatitis: a case report
1997
A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel
2004
E1505: Adjuvant chemotherapy +/- bevacizumab for early stage NSCLC—Outcomes based on chemotherapy subsets.
2016
Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival
2013
Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer
2008
Randomized Phase II Trial of Paclitaxel Plus Carboplatin or Gemcitabine Plus Cisplatin in Eastern Cooperative Oncology Group Performance Status 2 Non–Small-Cell Lung Cancer Patients: ECOG 1599
2007
Vinorelbine-Induced Pancreatitis: A Case Report
1997
Treatment preferences and advance care planning at end of life: The role of ethnicity and spiritual coping in cancer patients
2005
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
1984
Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion
1997
Overview of bladder cancer trials in the Radiation Therapy Oncology Group
2003
A Patient Preference Study Comparing Two Extended-Release Morphine Sulfate Formulations (Once-Daily Kadian?? versus Twice-Daily MS Contin??) for Cancer Pain
2000